Logistics & Transportation

Articles

Move expands security offerings for pharma and other industries

Company distributes in Africa and Central America regions

But volume and price dynamics remain volatile and uncertainty remains

New facility boosts manufacturing services for biologic projects

Plant targets Covid-19 vaccine supply for Israel, Europe and elsewhere

Originally developed by Ajinomoto for peptide synthesis, the technology has been expanded to include oligonucleotide production

Facility will up capacity and allow for more supply chain diversification

Pre-qualified 2-8°C shippers are designed for vaccines and biologics

Company scaling up manufacturing capacity and anticipates compatibility with its standard distribution channels

Optimizing supply chain by automating hospital restocking